Glomerular disease in 2014: Advances in basic science and translational medicine

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Knowledge of the pathogenesis of glomerular disease and approaches to therapy continued to advance in 2014. Key studies identified thrombospondin type-1 domain-containing protein 7A as an antigenic target in primary membranous nephropathy, and demonstrated efficacy of rituximab as maintenance therapy in relapsing or steroid-dependent nephrotic syndrome and antineutrophil cytoplasmic antibody-associated vasculitis.

Original languageEnglish (US)
Pages (from-to)46-47
Number of pages2
JournalNature Reviews Gastroenterology and Hepatology
Volume12
Issue number1
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Fingerprint Dive into the research topics of 'Glomerular disease in 2014: Advances in basic science and translational medicine'. Together they form a unique fingerprint.

Cite this